<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Babytongue0</id>
		<title>HistoryPedia - Внесок користувача [uk]</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Babytongue0"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=%D0%A1%D0%BF%D0%B5%D1%86%D1%96%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0:%D0%92%D0%BD%D0%B5%D1%81%D0%BE%D0%BA/Babytongue0"/>
		<updated>2026-04-07T05:18:24Z</updated>
		<subtitle>Внесок користувача</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Zinc_Autophagy&amp;diff=185416</id>
		<title>Zinc Autophagy</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Zinc_Autophagy&amp;diff=185416"/>
				<updated>2017-06-06T05:41:41Z</updated>
		
		<summary type="html">&lt;p&gt;Babytongue0: Створена сторінка: Direct [http://www.medchemexpress.com/Ingenol-Mebutate.html 75567-37-2 web] intracranial delivery of a drug is routinely practiced in particular clinical scenar...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Direct [http://www.medchemexpress.com/Ingenol-Mebutate.html 75567-37-2 web] intracranial delivery of a drug is routinely practiced in particular clinical scenarios. Performed the experiments: GC GS. Analyzed the data: GS GC JS  VL RJ. Contributed reagents/materials/analysis tools: RJ VL. Wrote the paper: GS GC JS VL RJ. References 1. Banks WA P assisted by K16ApoE. Within the first, agents that might bind towards the transporter peptide and mask its ApoE moiety are delivered to the brain by separate injections on the drug and also the peptide. Within the second, agents that usually do not bind towards the peptide might be delivered by mixing the two molecules and injecting only as soon as. The third strategy can be the most sensible this approach considers the likelihood that K16ApoE injected alone binds proteins inside the blood, all of which could transcytose [http://www.ncbi.nlm.nih.gov/pubmed/11967625 11967625] for the brain. This may be undesirable. To reduce such a possibility, K16ApoE is often premixed with any desired protein and made use of as the transporter. We mixed K16ApoE with cetuximab to illustrate that this method could be adopted to provide two anti-cancer drugs simultaneously to the brain. Direct intracranial delivery of a drug is routinely practiced in particular clinical situations. To be efficient and acceptable as an alternative and reasonably non-invasive suggests to provide a drug for the brain, a process in question need to enable comparable distribution from the drug within the brain to that obtained by intracranial injection. This premise was explored by delivering Evans Blue by both intracranial and K16ApoE-mediated procedures. The outcomes obtained deliver a striking contrast in favor with the K16ApoE-mediated approach such that whereas EB was localized inside a tiny area with the brain immediately after intracranial delivery, the dye appeared to have a homogeneous distribution all through the brain when delivered by means of K16ApoE, suggesting that the K16ApoE-based method is not only in a position to provide a molecule towards the brain, the approach may very well be preferable over other alternatives considering the fact that it enables distribution from the molecule all through the brain, which could be Delivery of `Small' Molecules for the Brain particularly desirable inside the remedy of specific brain-associated disorders. The BBB is virtually a `closed door' in the context of delivering therapeutics for the brain. It is known that receptors at the BBB supply a typical means for the transport of cognate ligands to the brain. Based on the benefits presented herein, coupled with all the reports that the BBB [http://www.ncbi.nlm.nih.gov/pubmed/15755315 15755315] may be transiently opened by activation from the adenosine receptor and endothelial cell B2 receptors by bradykinin, we propose that routine ligand/receptor binding also permits many other molecules to passively cross the barrier. Data presented in establish its possible to adjust clinical practice. As such, our approach presented herein appears to fulfill 3 of your 5 needs. No matter if our process fulfills the other two needs will need to be investigated. As a result, future investigation will will need to focus on evaluating clinical efficacy of your K16ApoE-mediated brain uptake of therapeutics inside the management of sufferers with brain cancer as well as other brain-associated issues. In this context, it really is important to note that we've got extremely recently demonstrated near-complete recovery of illness symptoms in a mouse model of Batten disease by K16ApoE-mediated delivery of recombinant tripeptidyl peptidase 1 in TPP1 knockout mice.&lt;/div&gt;</summary>
		<author><name>Babytongue0</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Methods_In_Mammalian_Autophagy_Research&amp;diff=183057</id>
		<title>Methods In Mammalian Autophagy Research</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Methods_In_Mammalian_Autophagy_Research&amp;diff=183057"/>
				<updated>2017-05-31T09:48:12Z</updated>
		
		<summary type="html">&lt;p&gt;Babytongue0: Створена сторінка: Brain delivery with the molecules is determined by the premise that upon injection into the vasculature, K16ApoE binds to proteins in the blood developing apoli...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Brain delivery with the molecules is determined by the premise that upon injection into the vasculature, K16ApoE binds to proteins in the blood developing apolipoprotein E -like entities. These entities are recognized by LDLR around the endothelial cell surface in the BBB as near-normal ligands and transcytosis is initiated. We further speculate that through ligandreceptor-mediated transcytosis transient pores are formed, which passively permit transport of other molecules towards the brain. Considering the fact that interaction of ApoE-like molecules with LDLR is definitely an active course of action and considering that this interaction is speculated to make transient pores across the BBB that allow passive transport of non-ligand molecules, we make use of the term `actively-passive transport ' to describe this phenomenon. Conceptually and mechanistically, APT is probably an integral aspect of the BBB. Indeed, the brain-uptake of I-125 by insulin gives proof of transient BBB permeability related with ligand-receptor-based signaling intrinsic to the BBB. Similar data have already been [http://www.bengals.net/members/searchmodem2/activity/362756/ Vimentin Autophagy] reported by Carman et al that demonstrate BBB permeability as a consequence of AR signaling. Thus, APT is actually a two-step procedure: transcytosis of a ligand via interaction with its receptor in the BBB followed by transient permeabilization with the BBB as a result of transcytosis. We further speculate that most, if not all, ligand-receptor interactions that take place on the cell surface elicit APT almost certainly even at non-BBB places. At this time, we don't know if APT allows one-way Delivery of `Small' Molecules to the Brain or two-way passage of molecules. Before proceeding to explore delivery of cisplatin and methotrexate by way of K16ApoE, we tested K16ApoE-mediated brain-uptake with 3 dye molecules. No brain-uptake of your dyes was observed when the dyes were very first mixed with K16ApoE then injected. This outcome may be explained by the possibility that dye binding to K16ApoE blocked the ApoE moiety from the peptide. Therefore the complex might have come to be inaccessible for the LDLR preventing transient opening of the BBB. Indeed, all of the three dyes we have employed are recognized to bind to proteins. However, the fact that the dyes crossed the BBB when administered separately in the peptide illustrates a sensible indicates to deliver such smaller molecules to the  brain. We've essentially created three diverse APT approaches to delivering various potential drugs to [http://www.ncbi.nlm.nih.gov/pubmed/ 23148522  23148522] the brainneffective tissue  distribution of the drugs injected. Intra-arterial injection of hyperosmolar agents including mannitol causes reversible disruption of the BBB however the technique is believed to result in lengthy disruption on the BBB and can also be believed to lead to significant expansion in the vascular volume. Drug delivery across the BBB by ultrasound generation of microbubbles is at present becoming investigated in various laboratories. Limitations of this technique include controlling the size on the microbubbles, and stopping irreversible damage to blood vessels and endothelial cells. Given that lipid solubility enhances passive diffusion of a molecule across the BBB, various investigators have pursued such chemical modification to provide drugs for the brain. Nonetheless, lipidization is an costly and timeconsuming procedure, and also the process itself might alter the pharmacokinetic properties from the drug. Within this paper we demonstrate the ability of a synthetic peptide carrier, K16ApoE, to deliver eight distinct molecules and I-125) to the brain with out requiring any chemical modification of the molecules.&lt;/div&gt;</summary>
		<author><name>Babytongue0</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Autophagy_Loose_Skin&amp;diff=180400</id>
		<title>Autophagy Loose Skin</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Autophagy_Loose_Skin&amp;diff=180400"/>
				<updated>2017-05-24T12:21:02Z</updated>
		
		<summary type="html">&lt;p&gt;Babytongue0: Створена сторінка: This sort of finding out, with no target field, is called unsupervised learning. Instead of trying to predict an outcome, K-Means tries to uncover patterns in t...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This sort of finding out, with no target field, is called unsupervised learning. Instead of trying to predict an outcome, K-Means tries to uncover patterns in the set of input fields. Records are grouped in order that records within a group or cluster have a tendency to be equivalent to each other, whereas records in different groups are dissimilar. K-Means functions by defining a set of starting cluster centers derived from the data. It then assigns every record to the cluster to which it truly is most equivalent based on the record's input field values. Right after all cases have been assigned, the cluster centers are updated to reflect the new set of records assigned to every cluster. The records are then checked once more to see whether or not they should really be reassigned to a distinctive cluster as well as the record assignment/cluster iteration approach continues till either the maximum quantity of iterations is reached or the transform among one particular iteration and also the next fails to exceed a specified threshold. Models When the target value was continuous, p values based on the F statistic had been employed. If some predictors are continuous and a few are categorical within the dataset, the criterion for continuous predictors continues to be primarily based around the p worth from a transformation and that for categorical predictors from the F statistic. Predictors are ranked by the following rules: Sort predictors by p worth in ascending order; If ties take place, comply with the rules for breaking ties amongst all categorical and all continuous predictors separately, then sort these two groups by the information file order of their initially predictors. A dataset of these characteristics was imported into Clementine application for further evaluation. The following models run on pre-processed dataset. Screening models This step removes variables and circumstances that  don't supply helpful data for prediction and problems warnings about variables that may not be useful. [http://vintagereissue.com/community/p/177415/ Endocytosis Autophagy] anomaly detection model. The target of anomaly detection is always to identify instances which can be unusual within information which is seemingly homogeneous. Anomaly detection is definitely an critical tool for detecting fraud, network intrusion, along with other rare events that might have wonderful significance but are difficult to uncover. This model was made use of to determine outliers or uncommon instances in  the data. In contrast to other modeling solutions that store rules about unusual instances, anomaly detection models store informatig of Physiological Traits of Yield As a result, 166 records with 22 traits like kernel quantity per ear, nitrogen fertilizer applied, plant density, sowing date-location, stem dry weight, kernel  dry weight, duration in the grain filling period, kernel growth price, Phosphorous fertilizer applied, imply kernel weight, grain yield, season duration, days to silking, leaf dry weight, mean kernel weight, cob dry weight, soil pH, potassium fertilizer applied, hybrid sort, defoliation, soil form, and the maximum kernel water content were recorded. The yield was set as the output variable along with the rest of variables as input variables. The final data set, prepared for running machine understanding algorithms, is presented as , Cramer's V, and lambda were carried out to check for attainable effects of calculation on function selection criteria.&lt;/div&gt;</summary>
		<author><name>Babytongue0</name></author>	</entry>

	</feed>